1.Associations Between Korean Coronary Heart Disease Risk Score and Cognitive Function in DementiaFree Korean Older Adults
Hanbit MUN ; Jae-Yong SHIM ; Heejin KIMM ; Hee-Cheol KANG
Journal of Korean Medical Science 2023;38(2):e11-
Background:
Cardiovascular risk is a modifiable factor that can help prevent dementia.Given the dearth of optimal treatment options, managing dementia risk factors is crucial. We examined the association between cardiovascular risk, as measured by the Korean coronary heart disease risk score (KRS), and cognitive function in dementia-free elderly individuals.
Methods:
We enrolled 8,600 individuals (average age: 69.74 years; 5,206 women) who underwent a medical evaluation from the National Health Insurance Service. KRS was calculated using age, sex, blood pressure, lipid profile, diabetes, and smoking status. Cognitive function was evaluated using Korean Dementia Screening QuestionnaireCognition (KDSQ-C). Scores of ≥ 6 indicated a cognitive decline. Logistic regression analysis was used to estimate the odds ratio (OR) and 95% confidence interval (CI). Weight, height, stroke history, coronary heart disease history, alcohol consumption, and physical activity engagement were adjusted.
Results:
The lowest, middle, and highest groups, according to the KRS, were 5,923 (68.9%), 2,343 (27.2%), and 334 (3.9%), respectively. The highest KRS group in all participants exhibited a greater risk of cognitive decline than the lowest KRS group (OR, 1.339; 95% CI, 1.034–1.734; P = 0.027). The highest KRS female group aged 71–75 years old exhibited greater cognitive decline than the corresponding lowest KRS group (OR, 1.595; 95% CI, 1.045–2.434; P = 0.031).
Conclusion
Individuals with high cardiovascular risk were associated with poorer cognitive function than those with low risk, especially older women. Cardiovascular risk factors should be carefully managed to promote healthy mental aging in dementia-free elderly individuals.
2.Susceptibility Weighted MR Imaging at 3T in Patients with Occlusion of Middle Cerebral Artery : Comparison with Diffusion Weighted Imaging Score (ASPECTS).
Heejin SHIM ; Hyun Seok CHOI ; So Lyung JUNG ; Kook Jin AHN ; Bum soo KIM
Journal of the Korean Society of Magnetic Resonance in Medicine 2011;15(3):219-225
PURPOSE: To describe the imaging findings at susceptibility weighted imaging (SWI) at 3T in patients with occlusion of middle cerebral artery, and to correlate the absence or presence of arterial bright foci in sylvian fissure, as one of their finding at SWI, with the diffusion weighted imaging (DWI) scores. MATERIALS AND METHODS: We included 12 patients with symptomatic unilateral occlusion of middle cerebral artery. Retrospective review of SWI and DWI was done. On DWI, size of infarction was analyzed according to the ASPECTS grading system. On SWI, presence of hemorrhage, dark blooming of intravascular clot, distension of medullary or cortical vein, and absence or presence of bright arterial foci in sylvian fissure were evaluated. RESULTS: Of 12 patients with symptomatic unilateral MCA occlusion, SWI showed dark blooming of intravascular clot in 8 patients (66.7%), distended medullary or cortical vein in 7 patients (58.3%), nonvisualization of arterial bright signal intensity in sylvian fissure in 7 patients (58.3%), and hemorrhage in one patient (8.3%). In comparison with DWI, patients with sylvian arterial bright signal intensity showed better ASPECTS score (6.4+/-4.1) than patients without arterial bright signal intensity (4.4+/-1.1), yet it was not statistically significant (p=0.267, t-test). CONCLUSION: SWI at 3T provides added diagnostic information including site of occlusion, collateral flow by arterial bright signal intensity in sylvian fissure and early hemorrhagic transformation in patients with symptomatic MCA occlusion.
Diffusion
;
Hemorrhage
;
Humans
;
Infarction
;
Infarction, Middle Cerebral Artery
;
Middle Cerebral Artery
;
Retrospective Studies
;
Stroke
;
Veins
3.Is There Any Age Cutoff to Treat Elderly Patients with Head and Neck Cancer? Comparing with Septuagenarians and Octogenarians.
Heejin KIM ; Seong Dong KIM ; Ye Ji SHIM ; Sang Yeon LEE ; Myung Whun SUNG ; Kwang Hyun KIM ; J Hun HAH
Journal of Korean Medical Science 2016;31(8):1300-1306
With the increase in life expectancy, age is no longer considered as a limitation for treatment. Nevertheless, the treatment of elderly patients with head and neck cancer (HNC) remains controversial. Here, we aimed to review our experience with the treatment for elderly patients, while particularly focusing on the differences among older old patients (septuagenarians vs. octogenarians). We retrospectively reviewed the records of 260 elderly patients who were assigned to 3 groups according to age: 70 years old ≤ group 1 < 75 years old, 75 years old ≤ group 2 < 80 years old, and group 3 ≥ 80 years old. The patients were assessed for comorbidities using the Adult Comorbidity Evaluation (ACE)-27, and the American Society of Anesthesia (ASA) physical status was also compared. Group 1, 2, and 3, consisted of 97, 102, and 61 patients, respectively. No significant difference in demographic data was noted among the groups. However, group 3 showed more comorbidities than groups 1 and 2. With regard to the initial treatment for HNC, radiation therapy (RT) was more frequently performed in group 3 than in groups 1 and 2. Among 7 patients of non-compliant to treatment in group 3, 6 patients had have performed RT. In group 3, a total of 18 patients underwent surgery, including microvascular free flap reconstruction and no significant difference in complications was observed postoperatively compared with group 1 and 2. Moreover, no significant difference was noted in overall survival between the groups, regardless of the treatment modality chosen. In conclusion, octogenarians with HNC should be more carefully managed than septuagenarians with HNC. Surgical treatment can be considered in octogenarians with HNC, if it can be tolerated.
Age Factors
;
Aged
;
Aged, 80 and over
;
Comorbidity
;
Head and Neck Neoplasms/mortality/*radiotherapy/*surgery
;
Humans
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome
4.Is There Any Age Cutoff to Treat Elderly Patients with Head and Neck Cancer? Comparing with Septuagenarians and Octogenarians.
Heejin KIM ; Seong Dong KIM ; Ye Ji SHIM ; Sang Yeon LEE ; Myung Whun SUNG ; Kwang Hyun KIM ; J Hun HAH
Journal of Korean Medical Science 2016;31(8):1300-1306
With the increase in life expectancy, age is no longer considered as a limitation for treatment. Nevertheless, the treatment of elderly patients with head and neck cancer (HNC) remains controversial. Here, we aimed to review our experience with the treatment for elderly patients, while particularly focusing on the differences among older old patients (septuagenarians vs. octogenarians). We retrospectively reviewed the records of 260 elderly patients who were assigned to 3 groups according to age: 70 years old ≤ group 1 < 75 years old, 75 years old ≤ group 2 < 80 years old, and group 3 ≥ 80 years old. The patients were assessed for comorbidities using the Adult Comorbidity Evaluation (ACE)-27, and the American Society of Anesthesia (ASA) physical status was also compared. Group 1, 2, and 3, consisted of 97, 102, and 61 patients, respectively. No significant difference in demographic data was noted among the groups. However, group 3 showed more comorbidities than groups 1 and 2. With regard to the initial treatment for HNC, radiation therapy (RT) was more frequently performed in group 3 than in groups 1 and 2. Among 7 patients of non-compliant to treatment in group 3, 6 patients had have performed RT. In group 3, a total of 18 patients underwent surgery, including microvascular free flap reconstruction and no significant difference in complications was observed postoperatively compared with group 1 and 2. Moreover, no significant difference was noted in overall survival between the groups, regardless of the treatment modality chosen. In conclusion, octogenarians with HNC should be more carefully managed than septuagenarians with HNC. Surgical treatment can be considered in octogenarians with HNC, if it can be tolerated.
Age Factors
;
Aged
;
Aged, 80 and over
;
Comorbidity
;
Head and Neck Neoplasms/mortality/*radiotherapy/*surgery
;
Humans
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome